中国P站

Intracranial atherosclerosis (ICAS), the narrowing of arteries within the brain, poses a significant risk for stroke, a leading cause of disability and mortality worldwide. Unlike atherosclerosis in other vascular beds, ICAS often presents with non-specific or silent symptoms until a significant event occurs, making early diagnosis crucial for timely intervention and prevention of devastating neurological outcomes. Traditional diagnostic methods, such as clinical evaluation and non-contrast computed tomography (CT), often lack the sensitivity and specificity required to detect early-stage ICAS or to differentiate it from other cerebrovascular diseases. Over the past few decades, significant advancements in neuroimaging techniques have revolutionized our ability to visualize intracranial vessels and identify subtle signs of atherosclerotic changes. These advanced imaging modalities, including Doppler ultrasound, computed tomography angiography (CTA), magnetic resonance angiography (MRA), and high-resolution magnetic resonance imaging (HR-MRI), offer non-invasive or minimally invasive ways to assess the intracranial vasculature, characterize atherosclerotic plaques, and evaluate hemodynamic consequences. The ability to detect ICAS at an early, potentially asymptomatic stage allows for the implementation of aggressive risk factor modification and targeted therapies, ultimately aiming to reduce the incidence of stroke and improve patient outcomes. This manuscript will provide a comprehensive overview of these advanced imaging techniques, highlighting their principles, advantages, limitations, and their role in the early diagnosis of intracranial atherosclerosis [1].

Description

Several advanced imaging techniques play a vital role in the early diagnosis and characterization of intracranial atherosclerosis. Transcranial Doppler (TCD) and transcranial color-coded duplex (TCCD) ultrasonography are non-invasive bedside techniques that utilize ultrasound waves to assess blood flow velocity in the major intracranial arteries. While TCD primarily measures blood flow velocity, TCCD adds color Doppler imaging to visualize the vessels and detect flow disturbances indicative of stenosis. These techniques are particularly useful for screening high-risk individuals, monitoring disease progression, and assessing the hemodynamic significance of identified stenoses. However, their accuracy can be limited by the acoustic window through the skull and the operator's expertise [2]. Computed tomography angiography (CTA) is a widely available and relatively fast imaging modality that involves the intravenous administration of iodinated contrast agents followed by rapid CT scanning. CTA provides high spatial resolution images of the intracranial arteries, allowing for the visualization of luminal narrowing and the identification of calcified plaques. Multi-detector CT technology has further enhanced the speed and image quality of CTA, making it a valuable tool for the detection and quantification of ICAS. However, CTA involves exposure to ionizing radiation and the risk of contrast-induced nephropathy or allergic reactions [3].

Magnetic resonance angiography (MRA) offers a non-ionizing alternative to CTA for visualizing intracranial vessels. Time-of-flight (TOF) MRA relies on the flow-related enhancement of blood to generate angiographic images, while phase-contrast (PC) MRA can provide information about blood flow direction and velocity. Contrast-enhanced MRA (CE-MRA) utilizes gadolinium-based contrast agents to improve vessel visualization, particularly for detecting subtle stenoses or non-calcified plaques. While MRA avoids radiation exposure, it can be more time-consuming than CTA and may be contraindicated in patients with certain metallic implants [4].

Furthermore, both CTA and conventional MRA primarily focus on the luminal narrowing and may not provide detailed information about the vessel wall and plaque characteristics. High-resolution magnetic resonance imaging (HR-MRI) represents a significant advancement in the imaging of intracranial atherosclerosis [5]. By employing specialized pulse sequences and high magnetic field strengths, HR-MRI allows for the direct visualization of the intracranial vessel wall and the detailed characterization of atherosclerotic plaques, including their composition (e.g., lipid-rich necrotic core, calcification, fibrous cap), presence of intraplaque hemorrhage, and vessel wall inflammation [6].

This detailed plaque characterization is crucial for identifying vulnerable plaques that are at high risk of rupture and subsequent stroke, even in the absence of significant luminal stenosis. Different HR-MRI sequences, such as T1-weighted, T2-weighted, proton density-weighted, and contrast-enhanced sequences, provide complementary information about plaque morphology and composition [7].

The ability of HR-MRI to directly visualize the vessel wall and plaque characteristics offers a significant advantage over lumenography-based techniques like CTA and conventional MRA in the early diagnosis and risk stratification of ICAS. Ongoing research continues to refine HR-MRI techniques and explore the use of novel contrast agents to further enhance plaque characterization and identify early markers of atherosclerosis [8].

Conclusion

The early diagnosis of intracranial atherosclerosis is paramount for preventing stroke and improving patient outcomes. Advanced neuroimaging techniques have significantly enhanced our ability to visualize the intracranial vasculature and detect subtle atherosclerotic changes before the onset of major neurological events. Doppler ultrasound techniques offer a non-invasive means for hemodynamic assessment and screening. CTA provides rapid, high-resolution luminal imaging and is valuable for detecting calcified plaques and significant stenoses. MRA offers a radiation-free alternative for visualizing intracranial vessels, particularly with the use of contrast enhancement. However, the advent of high-resolution magnetic resonance imaging (HR-MRI) represents a paradigm shift in the early diagnosis and risk stratification of ICAS. By directly visualizing the intracranial vessel wall and characterizing plaque morphology and composition, HR-MRI provides crucial information beyond luminal narrowing, allowing for the identification of vulnerable plaques and a more accurate assessment of stroke risk. While each imaging modality has its own strengths and limitations, the judicious application and interpretation of these advanced techniques, often in a complementary fashion, are essential for the early detection of intracranial atherosclerosis, enabling timely implementation of preventive strategies and ultimately reducing the burden of stroke associated with this prevalent cerebrovascular disease. Future research will likely focus on further refining these imaging techniques, developing novel contrast agents, and integrating imaging findings with clinical and genetic data to create more personalized approaches for the early diagnosis and management of intracranial atherosclerosis.

Acknowledgement

None

Conflict of Interest

None

References

1. Ritossa F (1996) Cell Stress Chaperones 1: 97-98.

   , ,

2. Hartl FU (1996) Nature 381: 571-579.

   , ,

3. Milani A, Basirnejad M, Bolhassani A, Gazali A, Stebbing J, et al. (2019) Immunotherapy 11: 215-239.

   , ,

4. De Maio A (1999) Shock 11: 1-12.

   , ,

5. Hartl FU, Hayer-Hartl M (2009) Nat Struct Mol Biol 16: 574581.

   , ,

6. Dattilo S, Mancuso C, Koverech G, Di Mauro P, Ontario ML, et al. (2015) Immun Ageing 12: 20.

   , ,

7. Kampinga HH, Hageman J, Vos MJ, Kubota H, Tanguay RM, et al. (2009) Cell Stress Chaperones 14: 105-111.

   , ,

8. Hightower LE, Guidon Jr PT (1989) J Cell Physiol 138: 257-266.

   , ,